Jim Simons Alaunos Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

$56.7 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.04 - $0.13 $15,280 - $49,660	382,000 New	382,000 $27,000
Q2 2023 Aug 11, 2023	SELL	$0.43 - $0.65 $222,396 - $336,180	-517,200 Reduced 50.72%	502,600 $256,000
Q1 2023 May 12, 2023	SELL	$0.46 - $0.81 $257,094 - $452,709	-558,900 Reduced 35.4%	1,019,800 $642,000
Q4 2022 Feb 13, 2023	BUY	$0.5 - $261.0 $789,350 - $412 Million	1,578,700 New	1,578,700 $1.03 Million
Q2 2022 Aug 12, 2022	SELL	$0.41 - $1.24 $393,624 - $1.19 Million	-960,060 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.62 - $1.17 $280,339 - $529,027	452,160 Added 89.03%	960,060 $626,000
Q4 2021 Feb 11, 2022	SELL	$1.09 - $1.89 $1.04 Million - $1.8 Million	-954,587 Reduced 65.27%	507,900 $554,000
Q3 2021 Nov 12, 2021	BUY	$1.44 - $2.73 $752,093 - $1.43 Million	522,287 Added 55.55%	1,462,487 $2.66 Million
Q2 2021 Aug 13, 2021	BUY	$2.63 - $3.67 $1.32 Million - $1.85 Million	503,600 Added 115.35%	940,200 $2.48 Million
Q1 2021 May 13, 2021	BUY	$2.82 - $5.6 $1.14 Million - $2.26 Million	402,941 Added 1197.13%	436,600 $1.57 Million
Q4 2020 Feb 10, 2021	SELL	$2.09 - $3.09 $316,099 - $467,343	-151,244 Reduced 81.8%	33,659 $85,000
Q3 2020 Nov 13, 2020	BUY	$2.39 - $3.43 $320,594 - $460,100	134,140 Added 264.25%	184,903 $466,000
Q2 2020 Aug 13, 2020	SELL	$2.2 - $3.71 $1.38 Million - $2.32 Million	-626,337 Reduced 92.5%	50,763 $167,000
Q1 2020 May 14, 2020	BUY	$1.9 - $4.98 $1.26 Million - $3.3 Million	663,029 Added 4712.02%	677,100 $1.66 Million
Q4 2019 Feb 13, 2020	SELL	$3.95 - $5.35 $460,309 - $623,456	-116,534 Reduced 89.23%	14,071 $66,000
Q3 2019 Nov 13, 2019	SELL	$4.13 - $6.94 $312,628 - $525,337	-75,697 Reduced 36.69%	130,605 $559,000
Q2 2019 Aug 12, 2019	BUY	$3.98 - $6.2 $821,081 - $1.28 Million	206,302 New	206,302 $1.2 Million

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $458M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account